A randomized controlled trial of geriatric liaison intervention in frail surgical oncology patients

Phase 3

• Conditions: cancer in the elderly; 10027655; 10043413

• Registration Number: NL-OMON30407
• Lead Sponsor: niversitair Medisch Centrum Groningen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 18 June 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 294

Inclusion Criteria

frail elderly patients in need for a cancer operation

Exclusion Criteria

unable to comply outcome questionaires
no compiance for follow-up

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Main study parameters/endpoints: The main endpoint is the cumulative incidence<br /><br>of delirium (measured with the Delirium Observation Scale and the DSM IV<br /><br>criteria) up to 10 days postoperatively. Secondary endpoints are: returning to<br /><br>the pre-operative living situation within 3 months postoperatively,the Physical<br /><br>Component Summary measure (PCS) of the SF-36, the Mental Component Summary<br /><br>measure (MCS) of the SF-36, complications during hospital stay including<br /><br>mortality, care Dependence Scale at discharge. Direct health care and<br /><br>non-health care costs will be used as economic indicators </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>see above</p><br>